Advances in Hematology / 2012 / Article / Tab 5

Research Article

DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil

Table 5

Clinical characteristics of patients with acute myeloid leukemia with or without DNMT3A mutations.

CharacteristicsNumber of pts (%)
DNMT3A mutated
Number of pts (%)
DNMT3A not mutated

Age (median)40.244.80.56
Sex
 Male50%   59.3%   0.68
 Female50%   40.7%  
Subtype FAB
 M00%7.2%  
 M160%   18.8%  
 M220%   30.4%   0.56
 M320%   20.3%  
 M40%18.8%  
 M50%1.4%  
 Not M30%2.9%  
Risk groups
 Favorable20%   29.8%  
 Intermediate80%   59.6%   1.000
 Unfavorable0%10.5%  
Leukocytes (×103) (median)20.676.410.28
Death50%   51.4%   1.000
Relapses50%   30.9%   0.58
Refractory20%   19.1%   0.96

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.